SuspendedPHASE1, PHASE2NCT02494492

Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose

Studying Uveitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Bahram BODAGHI, Professor
Assitance publique - Hopitaux de Paris
Intervention
intravitreous administration of regulator T-cells(other)
Enrollment
18 target
Eligibility
18 years · All sexes
Timeline
2013 – 2017

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02494492 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis →

← Back to all trials